The ⁶⁷Cu is considered as one of the most perspective radio isotopes in targeted radio-immunotherapy medical applications. ⁶⁷Cu is a β^–-emitter with a mean β^– energy, which allows treating tumors in size up to about 4 mm. Its decay is followed by emission of low energy gamma-rays suitable for gamma-camera imaging. The about three days half-life (T_1/2 = 61.83 h) is optimal for human applications. However, one of the main drawback factors for its application is still the limited supply of ⁶⁷Cu. There are several possibilities to produce ⁶⁷Cu. High flux reactors, charged particle accelerators and high-energy bremsstrahlung radiations can be used to produce ⁶⁷Cu. In this work we have studied one of the promising charged particle production routes based on the ⁶⁴Ni(α,p)⁶⁷Cu nuclear reaction. Cross sections for formation of ^67,64,61,60Cu, ^62,63Zn and ^56,57Ni were studied up to 50 MeV alpha-particle energy on nickel targets with natural isotopic composition.

在⁶⁷铜被认为是定向的无线电免疫治疗的医疗应用的最视角放射性同位素之一。⁶⁷铜为β ^-发射极，平均β ^-能量，这允许治疗肿瘤的大小达到约4mm。其衰减之后，发出适合于伽马相机成像的低能伽马射线。约三天的半衰期（T _1/2  = 61.83 h）最适合人类应用。但是，其应用的主要缺点之一仍然是⁶⁷ Cu的供应有限。生产⁶⁷ Cu有几种可能性。高通量反应堆，带电粒子加速器和高能致辐射可以用来产生⁶⁷铜 在这项工作中，我们研究了基于⁶⁴ Ni（α，p）⁶⁷ Cu核反应的一种有前途的带电粒子生产路线。研究了在具有天然同位素组成的镍靶材上，形成高达50 ^MeVα粒子能的^67,64,61,60 Cu，^62,63 Zn和^56,57 Ni的横截面。